Ostatní
Návod 
Nurix Therapeutics, Inc.
NRIX
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.0B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
0%
ROA
0%
PE
-6
PS
18
Cena 1R
8-23
⌀ Cena
12.24
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
14-04-2026
Poslední dividenda
Profil
Nurix Therapeutics, Inc., biofarmaceutická společnost, se zaměřuje na objevování, vývoj a komercializaci malých molekul terapií pro léčbu rakoviny a imunitních poruch. Společnost vyvíjí NX-2127, perorálně dostupný Brutonův degradér tyrozinkinázy (BTK) pro léčbu relabujících nebo refrakterních malignit B-buněk; NX-5948, perorálně biologicky dostupný degradér BTK pro léčbu relabujících nebo refrakterních malignit B-buněk a autoimunitních onemocnění; a NX-1607, perorálně dostupný inhibitor Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) pro imuno-B onkologické indikace. Vyvíjí se také NX- 0255, CBL-B inhibitor pro ex vivo použití k posílení adoptivní T-buněčné terapie; a DeTIL-0255, který je ve fázi 1 klinické studie pro léčbu gynekologických karcinomů, včetně karcinomu vaječníků, endometria a děložního čípku. Společnost uzavřela strategickou dohodu o spolupráci s firmou Gilead Sciences, Inc. pro pacienty s rakovinou a jinými náročnými onemocněními a se společností Sanofi S.A. Společnost byla dříve známá jako Nurix Inc. a v říjnu 2018 změnila své jméno na Nurix Therapeutics, Inc. Společnost byla založena v roce 2009 a sídlí v San Franciscu v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
286
Založení
2020-07-24
Podobné společnosti
$ 18.44
+ $ 0.81
$ 13.67
+ $ 0.42
$ 14.19
+ $ 0.29
$ 23.89
+ $ 0.65
$ 7.87
- $ 0.01
$ 11.33
+ $ 0.12
$ 10.29
+ $ 0.43
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 84.0 | 84.0 | 54.5 | 77.0 | 38.6 | 29.8 | 17.8 | 31.1 | 37.4 | |
| Cost of Revenues | 157.4 | 18.9 | 221.6 | 189.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | -73.4 | 65.1 | -167.1 | -112.2 | 38.6 | 29.8 | 17.8 | 31.1 | 37.4 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 13.6 | 7.9 | 44.1 | 18.5 | 13.3 | 12.6 | 12.1 | 16.6 | 15.2 | 18.5 | |
| Cost of Revenues | 4.6 | 5.0 | 78.1 | 69.7 | 67.2 | 55.5 | 48.9 | 50.0 | 3.8 | 3.4 | |
| Gross Profit | 8.9 | 2.9 | -34.0 | -51.2 | -53.9 | -42.9 | -36.8 | -33.4 | 11.4 | 15.1 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 189.1 | 184.5 | 116.4 | 66.5 | 45.0 | 40.5 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 42.9 | 38.0 | 31.2 | 16.3 | 8.3 | 6.7 | |
| Depreciation & Amortization | 18.9 | 18.9 | 8.0 | 13.7 | 10.8 | 6.1 | 2.2 | 2.4 | 3.0 | |
| Total Operating Expenses | 212.3 | 350.8 | 45.9 | 232.1 | 222.5 | 147.6 | 82.8 | 53.4 | 47.2 | |
| Operating Income | -285.7 | -285.7 | -213.0 | -155.1 | -183.9 | -117.9 | -65.0 | -22.2 | -9.7 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 47.8 | 47.9 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 9.0 | 10.6 | ||
| Depreciation & Amortization | 9.3 | 5.0 | 2.2 | 2.4 | 1.2 | 2.4 | 2.3 | 2.0 | 3.8 | 3.4 | ||
| Total Operating Expenses | 92.0 | 94.3 | 14.3 | 11.7 | 10.7 | 11.7 | 11.7 | 11.8 | 56.7 | 58.5 | ||
| Operating Income | -83.1 | -91.4 | -48.3 | -62.9 | -64.7 | -54.6 | -48.5 | -45.2 | -45.3 | -40.0 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 22.0 | 22.0 | 19.7 | 11.1 | 3.5 | 0.8 | 1.2 | 0.8 | 0.8 | |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | -14.3 | 0.0 | 0.0 | 0.0 | -0.8 | |
| Other Expense | 22.0 | 22.0 | 19.7 | 11.1 | 3.5 | 0.8 | 1.2 | 0.8 | 0.8 | |
| IBT | -263.7 | -263.7 | -193.3 | -143.9 | -180.4 | -117.1 | -63.8 | -21.5 | -8.9 | |
| Income Tax Expense | 0.8 | 0.8 | 0.3 | 0.0 | -14.3 | 0.1 | -20.5 | 0.2 | 0.5 | |
| Net Income | -264.5 | -264.5 | -193.6 | -143.9 | -166.0 | -117.2 | -43.2 | -21.7 | -9.4 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 4.9 | 5.0 | 5.6 | 6.5 | 6.1 | 5.7 | 4.1 | 3.8 | 3.4 | 3.0 | ||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 7.9 | 0.0 | ||
| Other Expense | 4.9 | 5.0 | 5.6 | 6.5 | 6.1 | 5.7 | 4.1 | 3.8 | 3.4 | 3.0 | ||
| IBT | -78.2 | -86.4 | -42.7 | -56.4 | -58.5 | -48.9 | -44.5 | -41.4 | -42.0 | -37.0 | ||
| Income Tax Expense | 0.0 | 0.0 | 0.8 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 7.9 | 3.4 | ||
| Net Income | -78.2 | -86.4 | -43.5 | -56.4 | -58.5 | -49.0 | -44.5 | -41.5 | -42.0 | -37.0 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-2.65 | $-3.42 | $-2.73 | $-2.76 | $-1.04 | $-0.59 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-2.65 | $-3.42 | $-2.73 | $-2.76 | $-1.04 | $-0.59 | |
| Shares Outstanding | 95.1 | 86.7 | 67.1 | 54.3 | 48.6 | 42.9 | 15.7 | 20.8 | 16.1 | |
| Diluted Shares Outstanding | 95.1 | 86.7 | 67.1 | 54.3 | 48.6 | 42.9 | 15.7 | 20.8 | 16.1 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.77 | $-0.68 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.77 | $-0.68 | ||
| Shares Outstanding | 95.1 | 84.2 | 83.9 | 83.6 | 78.4 | 72.8 | 62.4 | 54.9 | 54.7 | 54.4 | ||
| Diluted Shares Outstanding | 95.1 | 84.2 | 83.9 | 83.6 | 78.4 | 72.8 | 62.4 | 54.9 | 54.7 | 54.4 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 116.8 | 110.0 | 54.6 | 64.5 | 80.5 | 119.4 | 34.8 | 25.6 | |
| Short Term Investments | 326.3 | 499.6 | 233.3 | 244.7 | 215.2 | 161.8 | 2.9 | 13.4 | |
| Total Cash & ST Investments | 443.1 | 609.6 | 287.9 | 309.1 | 295.7 | 281.1 | 37.7 | 39.0 | |
| Accounts Receivable | 0.6 | 1.5 | 0.0 | 0.0 | 6.2 | 11.3 | 0.0 | 0.0 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 6.5 | 8.3 | 7.6 | 9.3 | 9.2 | 5.9 | 1.6 | 1.6 | |
| Total Current Assets | 450.2 | 619.4 | 295.5 | 318.4 | 311.1 | 298.4 | 39.4 | 40.7 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 78.4 | 84.3 | 75.9 | 110.0 | 99.0 | 116.8 | 49.8 | 54.6 | 42.3 | 59.0 | |
| Short Term Investments | 350.4 | 401.5 | 473.8 | 499.6 | 349.0 | 326.3 | 194.2 | 233.3 | 216.5 | 222.2 | |
| Total Cash & ST Investments | 428.8 | 485.8 | 549.7 | 609.6 | 448.1 | 443.1 | 244.0 | 287.9 | 258.9 | 281.2 | |
| Accounts Receivable | 1.7 | 19.0 | 9.1 | 1.5 | 0.8 | 0.6 | 0.8 | 0.0 | 2.0 | 0.0 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.0 | |
| Other Current Assets | 10.1 | 10.5 | 4.9 | 8.3 | 7.2 | 6.5 | 6.2 | 7.6 | 7.1 | 8.8 | |
| Total Current Assets | 440.6 | 515.3 | 563.7 | 619.4 | 456.0 | 450.2 | 251.0 | 295.5 | 267.9 | 290.0 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 47.4 | 45.9 | 48.0 | 29.5 | 25.3 | 6.7 | 3.9 | 4.4 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 10.3 | 0.0 | 7.4 | 63.9 | 137.2 | 90.9 | 0.5 | 0.0 | |
| Other Long-Term Assets | 3.1 | 4.1 | 4.7 | 4.9 | 3.1 | 0.3 | 0.3 | 0.3 | |
| Total Long-Term Assets | 60.8 | 50.0 | 60.1 | 98.3 | 165.7 | 97.9 | 4.7 | 4.7 | |
| Total Assets | 511.0 | 669.3 | 355.6 | 416.8 | 476.8 | 396.3 | 44.0 | 45.4 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 73.5 | 69.0 | 44.8 | 45.9 | 44.2 | 47.4 | 47.2 | 48.0 | 25.6 | 28.4 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 1.0 | 0.0 | 0.0 | 0.0 | 9.5 | 10.3 | 11.2 | 8.3 | 9.9 | 27.5 | |
| Other Long-Term Assets | 7.4 | 7.2 | 6.5 | 4.1 | 3.9 | 3.1 | 3.3 | 3.8 | 4.8 | 4.7 | |
| Total Long-Term Assets | 81.9 | 76.2 | 51.3 | 50.0 | 57.6 | 60.8 | 61.7 | 69.0 | 40.2 | 60.6 | |
| Total Assets | 522.5 | 591.6 | 615.0 | 669.3 | 513.6 | 511.0 | 312.7 | 364.5 | 308.2 | 350.6 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 2.8 | 11.5 | 6.4 | 5.1 | 6.7 | 3.4 | 1.6 | 1.3 | |
| Short-Term Debt | 7.9 | 8.0 | 13.9 | 5.5 | 3.8 | 7.6 | 4.6 | 2.8 | |
| Other Current Liabilities | 23.3 | 36.8 | 24.9 | 22.4 | 14.5 | 0.7 | 0.3 | 0.3 | |
| Current Liabilities | 80.8 | 95.9 | 87.0 | 70.7 | 66.3 | 44.5 | 16.1 | 32.8 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 8.6 | 6.0 | 8.4 | 11.5 | 3.9 | 2.8 | 5.9 | 6.4 | 2.2 | 4.5 | |
| Short-Term Debt | 3.8 | 5.2 | 6.6 | 8.0 | 6.6 | 7.9 | 7.3 | 15.0 | 10.7 | 11.2 | |
| Other Current Liabilities | 44.0 | 36.1 | 43.0 | 36.8 | 26.9 | 22.6 | 27.9 | 17.5 | 16.5 | 12.5 | |
| Current Liabilities | 82.4 | 75.6 | 90.0 | 95.9 | 86.3 | 80.8 | 87.6 | 87.0 | 61.5 | 72.3 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 20.9 | 20.3 | 23.1 | 6.4 | 9.2 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 20.9 | 28.3 | 30.6 | 12.0 | 13.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | -38.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 140.3 | 142.4 | 155.1 | 113.1 | 134.5 | 106.1 | 101.8 | 82.2 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 52.7 | 46.7 | 20.0 | 20.3 | 20.6 | 20.9 | 21.8 | 46.3 | 5.3 | 7.5 | |
| Capital Leases | 56.5 | 51.9 | 26.6 | 28.3 | 27.1 | 20.9 | 21.8 | 23.1 | 8.0 | 9.3 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.9 | -10.2 | -14.7 | |
| Total Liabilities | 150.2 | 144.0 | 134.1 | 142.4 | 136.7 | 140.3 | 143.9 | 164.0 | 74.4 | 90.7 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -631.3 | -738.8 | -545.2 | -401.3 | -220.9 | -103.7 | -60.5 | -38.8 | |
| Comprehensive Income | -0.1 | 0.2 | -0.7 | -4.3 | -0.6 | 0.1 | 0.0 | 0.0 | |
| Total Common Equity | 370.7 | 527.0 | 200.5 | 303.7 | 342.3 | 290.3 | -57.7 | -36.8 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -925.0 | -838.6 | -795.1 | -738.8 | -680.2 | -631.3 | -586.7 | -545.2 | -503.2 | -466.3 | |
| Comprehensive Income | 0.1 | 0.0 | 0.2 | 0.2 | 0.3 | -0.1 | -0.4 | -0.7 | -1.2 | -1.9 | |
| Total Common Equity | 372.3 | 447.6 | 480.9 | 527.0 | 376.9 | 370.7 | 168.7 | 200.5 | 233.8 | 259.9 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 28.8 | 28.3 | 30.6 | 12.0 | 13.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 370.7 | 527.0 | 200.5 | 303.7 | 342.3 | 290.3 | -57.7 | -36.8 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 372.3 | 447.6 | 480.9 | 527.0 | 376.9 | 370.7 | 168.7 | 200.5 | 233.8 | 259.9 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -165.0 | -264.5 | -193.6 | -143.9 | -180.4 | -117.2 | -43.2 | -21.7 | -9.4 | |
| Depreciation & Amortization | 15.1 | 18.9 | 16.4 | 13.7 | 10.8 | 6.1 | 2.2 | 2.4 | 3.0 | |
| Stock-Based Compensation | 33.1 | 38.0 | 33.9 | 33.7 | 28.1 | 15.8 | 4.3 | 0.5 | 0.4 | |
| Change Working Capital | 22.9 | -31.6 | -18.4 | 20.1 | -19.0 | 9.1 | 36.4 | 19.5 | -25.3 | |
| Change In Accounts Receivable | 0.0 | 0.0 | 0.0 | 0.0 | 6.0 | -6.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | 0.0 | -0.6 | 5.2 | 1.6 | 0.1 | 1.6 | 1.2 | 0.3 | -0.5 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.8 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 20.3 | -10.2 | -11.0 | -4.9 | 0.6 | 1.8 | 0.3 | -0.1 | 0.0 | |
| Cash from Operations | -101.0 | 0.0 | 0.0 | -81.4 | -159.8 | -84.4 | -0.1 | 0.6 | -31.7 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -78.2 | -86.4 | -43.5 | -56.4 | -58.5 | -49.0 | -44.5 | -41.5 | -42.0 | -37.0 | |
| Depreciation & Amortization | 4.6 | 5.0 | 5.1 | 4.1 | 4.3 | 4.1 | 4.1 | 3.9 | 3.8 | 3.4 | |
| Stock-Based Compensation | 0.0 | 9.8 | 10.4 | 8.7 | 8.5 | 8.8 | 8.8 | 7.8 | 8.0 | 8.4 | |
| Change Working Capital | -1.6 | 16.5 | -32.5 | -14.0 | 0.4 | -2.7 | -5.9 | -10.2 | 53.9 | -14.8 | |
| Change In Accounts Receivable | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2.0 | -2.0 | |
| Change In Accounts Payable | 3.0 | 2.2 | -2.7 | -3.2 | 7.6 | 1.1 | -2.5 | -0.9 | 4.7 | -1.2 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -4.9 | 4.9 | |
| Other Non-cash Items | 7.3 | -2.2 | -2.7 | -3.6 | -3.5 | -3.4 | -2.2 | -2.9 | 6.9 | -1.2 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 21.7 | -41.1 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -9.9 | -14.0 | -9.3 | -8.4 | -12.2 | -5.7 | -4.6 | -1.7 | -1.6 | |
| Acquisitions | 24.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -442.9 | -455.7 | -708.0 | -246.3 | -239.4 | -348.5 | -275.2 | -9.4 | -12.9 | |
| Sales of Investment | 365.6 | 617.5 | 459.5 | 323.0 | 278.8 | 245.9 | 25.4 | 19.5 | 54.5 | |
| Other Investing Activities | -154.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | -87.2 | 0.0 | 0.0 | 68.3 | 27.2 | -108.3 | -254.4 | 8.5 | 40.0 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -5.1 | -2.7 | -2.7 | -3.5 | -2.1 | -2.3 | -1.9 | -2.9 | -2.6 | -2.5 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 38.4 | 0.0 | -38.4 | 88.5 | -25.2 | |
| Investments | -174.3 | -103.0 | -68.2 | -110.2 | -298.2 | -129.8 | -225.1 | -54.8 | -88.4 | -74.6 | |
| Sales of Investment | 179.8 | 156.2 | 142.3 | 139.2 | 159.5 | 110.8 | 96.0 | 93.2 | 76.6 | 99.8 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -88.5 | 25.2 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -14.4 | 22.8 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -9.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 29.4 | 28.3 | -2.3 | 18.7 | -1.1 | 13.0 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 241.1 | 0.0 | 0.0 | 3.2 | 19.4 | 150.2 | 218.1 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 254.2 | 0.0 | 0.0 | 3.2 | 97.8 | 3.7 | 120.9 | 0.1 | 0.5 | |
| Cash from Financing | 246.0 | 0.0 | 0.0 | 3.2 | 117.2 | 153.9 | 339.0 | 0.1 | 0.5 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 56.5 | 4.6 | 25.3 | -1.7 | 1.2 | -1.7 | -0.3 | -1.5 | 22.6 | -1.3 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.7 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.7 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.9 | 1.7 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 57.8 | 137.0 | 55.4 | -9.8 | -15.4 | -38.7 | 84.5 | 9.2 | 8.8 | |
| Closing Cash Balance | 116.8 | 247.9 | 110.9 | 55.5 | 65.4 | 80.8 | 119.5 | 35.0 | 25.8 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 168.5 | -5.8 | 8.3 | -34.1 | 11.0 | -17.7 | 67.0 | -4.8 | 12.3 | -16.7 | |
| Closing Cash Balance | 247.0 | 79.4 | 85.2 | 76.8 | 110.9 | 99.9 | 116.8 | 49.8 | 54.6 | 43.2 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -110.9 | -263.5 | -181.9 | -89.8 | -172.1 | -90.0 | -4.6 | -1.1 | -33.3 | |
| Real Free Cash Flow | -144.0 | -301.4 | -215.8 | -123.4 | -200.2 | -105.8 | -8.9 | -1.6 | -33.7 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -73.0 | -60.1 | -65.8 | -64.6 | -50.9 | -44.5 | -41.6 | -44.8 | 19.2 | -43.6 | |
| Real Free Cash Flow | -73.0 | -69.9 | -76.2 | -73.3 | -59.4 | -53.3 | -50.5 | -52.7 | 11.1 | -52.0 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -5.7 | -298.1 | -1.4 |
| P/S | 17.8 | 932.7 | 9.4 |
| P/B | 4 | 138.5 | 5.2 |
| P/FCF | -5.1 | -349.6 | -1.5 |
| Market cap | $1.0 | $5.2 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 3.1 % | 0 % |
| Debt to Income | -21.4 % | -8.3 % | 0 % |
| Debt to Free cash flow | -19.3 % | -652.8 % | 0 % |
| Interest expense percentage | 0 % | 1.6 % | 44.7 % |
| Current ratio | 5.4 | 4.7 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -71 % | -36.2 % | 0 % |
| ROA | -50.6 % | -27.5 % | 0 % |
| CapEx to Revenue | 16.7 % | 18.7 % | 0 % |
| RaD to Revenue | 0 % | 313.2 % | 0 % |
| ROEM | 293,636.4 | 96395.4 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | -87.4 % | 77.2 % | 68.7 % |
| Operating margin | -340.2 % | -319 % | 35.5 % |
| Net margin | -314.9 % | -283.7 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 95.1 mil | 52.0 mil |
| Employee count | 0.3 tis | 0.2 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
